{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:04:14Z","timestamp":1785150254339,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijid.2025.108207","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T07:08:18Z","timestamp":1763276898000},"page":"108207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Successful treatment of refractory Helicobacter pylori infection with a potassium-competitive acid blocker-based regimen: A case report"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3873-3107","authenticated-orcid":false,"given":"Aneurin C.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb E.","family":"Rux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8336","key":"10.1016\/j.ijid.2025.108207_bib0001","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijid.2025.108207_bib0002","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter pylori in health and disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"issue":"36","key":"10.1016\/j.ijid.2025.108207_bib0003","doi-asserted-by":"crossref","first-page":"12818","DOI":"10.3748\/wjg.v20.i36.12818","article-title":"Hematologic manifestations of Helicobacter pylori infection","volume":"20","author":"Campuzano-Maya","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijid.2025.108207_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211014087","article-title":"Treatment approach of refractory helicobacter pylori infection: a comprehensive review","volume":"12","author":"Cort\u00e9s","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.ijid.2025.108207_bib0005","series-title":"Voquezna Triple Pak (vonoprazan tablets; amoxicillin capsules; clarithromycin tablets) and Voquezna Dual Pak (vonoprazan tablets; amoxicillin capsules): US prescribing information","year":"2023"},{"issue":"2","key":"10.1016\/j.ijid.2025.108207_bib0006","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.ijid.2025.108207_bib0007","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in helicobacter pylori: a systematic review and meta-analysis in world health organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ijid.2025.108207_bib0008","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.ijid.2025.108207_bib0009","doi-asserted-by":"crossref","unstructured":"Scott D.R., Sachs G., Marcus EA. The role of acid inhibition in Helicobacter Pylori Eradication. F1000Res. 2016; 5: F1000 Faculty Rev-1747. Published 2016 Jul 19. doi:10.12688\/f1000research.8598.1.","DOI":"10.12688\/f1000research.8598.1"},{"issue":"1","key":"10.1016\/j.ijid.2025.108207_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12998\/wjcc.v4.i1.5","article-title":"Treatment of Helicobacter pylori infection: current and future insights","volume":"4","author":"Safavi","year":"2016","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.ijid.2025.108207_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/1756283X17745776","article-title":"Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date","volume":"11","author":"Sugano","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"issue":"4","key":"10.1016\/j.ijid.2025.108207_bib0012","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17425255.2018.1461835","article-title":"Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine","volume":"14","author":"El Rouby","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"10.1016\/j.ijid.2025.108207_bib0013","first-page":"693","article-title":"Potassium-competitive acid blockers: present and potential utility in the armamentarium for acid peptic disorders","volume":"18","author":"Wong","year":"2022","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"43","key":"10.1016\/j.ijid.2025.108207_bib0014","doi-asserted-by":"crossref","first-page":"16029","DOI":"10.3748\/wjg.v20.i43.16029","article-title":"CYP2C19 polymorphism influences helicobacter pylori eradication","volume":"20","author":"Kuo","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"34","key":"10.1016\/j.ijid.2025.108207_bib0015","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.3748\/wjg.v25.i34.5097","article-title":"Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness","volume":"25","author":"Ierardi","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ijid.2025.108207_bib0016","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","article-title":"Vonoprazan triple and dual therapy for helicobacter pylori infection in the United States and Europe: randomized clinical trial","volume":"163","author":"Chey","year":"2022","journal-title":"Gastroenterology"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:54:15Z","timestamp":1783018455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225004291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":16,"alternative-id":["S1201971225004291"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108207","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of refractory Helicobacter pylori infection with a potassium-competitive acid blocker-based regimen: A case report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108207"}}